AzTrials
AzTrials

Employee Well-beingRECHARJME-RCTNCT07322354

Effectiveness of a Multi-Modal Workplace Rest Cabin on Worker Well-Being

A study testing Recharjme Multi-Modal Rest Cabin in people with Employee Well-being and Work-related Outcomes, run by Laval University at 4 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examines whether access to a rest cabin in the workplace supports employee well-being. Employees of a Canadian insurance company are randomly assigned to one of two groups: immediate access to the rest cabin or a waiting-list control group that receives access after one month. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Employee Well-being, Work-related Outcomes
What is being tested?
Recharjme Multi-Modal Rest Cabin
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
4 sitesCanada
Study dates
1 May 2024to 10 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Employee of participating insurance company
  • Aged 18 or older

Who cannot join

  • Mental health leave in past year
  • Diagnosed mental health disorder

Trial locations and contacts

4 sites in 1 country.

Canada4 sites

  • Worksite 3

    Longueuil, Quebec

  • Worksite 3

    Mississauga, Ontario

  • Worksite 1

    Québec, Quebec

  • Worksite 2

    Québec, Quebec

Other trials in Canada

About this study

Official title: A Pragmatic Randomized Controlled Trial on the Effectiveness of a Multi-Modal Rest Cabin in Boosting Worker Well-Being

This study examines whether access to a rest cabin in the workplace supports employee well-being. Employees of a Canadian insurance company are randomly assigned to one of two groups: immediate access to the rest cabin or a waiting-list control group that receives access after one month. The rest cabin is installed directly in the workplace and can be reserved for short sessions during the workday. It offers multiple relaxation options, including guided meditation, massage therapy, light therapy, and a zero-gravity chair. Employees choose which options to use during each session. Participants complete questionnaires before group assignment and again one month later. Employees who receive immediate access to the cabin also complete additional follow-up questionnaires at later time points. The study compares changes in general well-being and work-related outcomes between employees who have access to the cabin and those who do not during the initial study period.

Read the detailed description

This pragmatic randomized controlled trial evaluates the effects of a multi-modal rest cabin on general and work-related well-being among employees of a Canadian insurance company. The study takes place in real-world workplace settings across multiple office locations. After providing informed consent, participants complete a baseline survey assessing general well-being and work-related outcomes. Participants are then randomly assigned to one of two conditions: (1) immediate access to the rest cabin or (2) a waiting-list control condition with delayed access. Employees assigned to the immediate-access group are encouraged to use the rest cabin over a four-week period. Cabin sessions are self-scheduled during work hours and are designed to be brief. The rest cabin is fully enclosed and located within the workplace. It includes several relaxation modalities, such as guided meditation, massage therapy, light therapy, and a zero-gravity chair. Participants are free to select and combine modalities based on their preferences during each session. Participants in both the immediate-access group and the waiting-list control group complete a follow-up survey one month after the baseline assessment. To examine whether any observed changes are maintained over time, participants in the immediate-access group also complete additional follow-up surveys two months and four months after baseline. It is hypothesized that workers in the experimental (vs. control) group would have better changes in scores in their general (positive and negative affect, flourishing, anxiety, depression, mindful attention awareness, insomnia) and workplace (thriving at work, burnout, absenteeism, presenteeism, job satisfaction, psychological detachment from work) positive and negative well-being when comparing Time 1 (follow-up survey) to Time 0 (baseline) (H1). Specific to those in the experimental condition, it is hypothesized that: positive changes observed following cabin use (at Time 1) would remain evident at the subsequent follow-up timepoints (Times 2 and 3), relative to baseline (H2), and changes in well-being outcomes between Time 1 and Time 0 would be greater for those who have used the cabin more often (H3). It is also hypothesized that: 4) the change in outcomes between T1 and T0 associated with being in the experimental (vs. control) condition (as discussed in H1) would be mediated by changes in psychological detachment from work and mindfulness awareness (H4), and 5) the relationship between cabin use frequency and changes in well-being outcomes (as discussed in H3) would be mediated by changes in psychological detachment and mindfulness awareness (also between T1 and T0; H5).

Being tested
Recharjme Multi-Modal Rest Cabin
Keywords
Workplace well-being, Rest cabin, Micro-breaks, Burnout, Workplace intervention, Recovery at work, Employee mental health, Mindful attention awareness, Psychological detachment from work
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Recharjme Multi-Modal Rest CabinDevice

    Enclosed workplace cabin with guided meditation, massage, luminotherapy, and zero-gravity chair.

Study groups in NCT07322354
Study groupRoleWhat they receive
Rest Cabin UseExperimentalParticipants are encouraged to use the Recharjme cabin for one month (four weeks) at a frequency of three times a week, preferably between 9 a.m. and 4 p.m.
Receives: Device: Recharjme Multi-Modal Rest Cabin
Waiting List ControlNo interventionNo cabin access for four weeks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presenteeism (impaired productivity and troublesome symptoms at work)

    Measured using the Employment Absence and Productivity Scale; Min.: 1; Max.: 5; Higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  2. Absenteeism

    Calculation based on the World Health Organization Health and Work Performance Questionnaire; Min.: 0; Max.: 100; Higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  3. Job satisfaction

    Measured using an adapted item from Life in Transition Survey; Min.: 1; Max.: 5; Higher scores indicating a more positive outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  4. Anxiety and depression

    Measured using the two subscales of the Patient Health Questionnaire-4; Min.: 1; Max.: 4; Higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  5. Insomnia

    Measured using the Insomnia Severity Index; Min.: 0; Max.: 4; Higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  6. Burnout (physical fatigue, cognitive weariness, emotional exhaustion)

    Measured using the three subscales of the Shirom-Melamed Burnout Measure; Min.: 1; Max.: 7; Higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  7. Flourishing

    Measured using the Flourishing Scale; Min.: 1; Max.: 7; Higher scores indicating a more positive outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  8. Thriving at work

    Measured using Index of Psychological Well-Being at Work (Thriving at Work Subscale); Min.: 0; Max.: 5; Higher scores indicating a more positive outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  9. Mindful attention awareness

    Measured using the Mindful Attention Awareness Scale (Carlson \& Brown, 2005); Min.: 1; Max.: 6; Higher scores indicating a more positive outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  10. Psychological detachment from work

    Measured using adapted items from Recovery Experience Questionnaire; Min.: 1; Max.: 5; Higher scores indicating a more positive outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

  11. Positive and Negative Affect

    Measured using the two subscales of the Positive and Negative Affect Schedule; Min.: 1; Max.: 5; For positive affect: higher scores indicating a more positive outcome; For negative affect, higher scores indicating a more negative outcome.

    Measured: Time 0 (baseline) to time 3 (four months after baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start1 May 2024
  3. Primary completion10 Apr 2025
  4. Study completion10 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07322354
Sponsor's protocol ID
Recharjme-RCT-2024
Other IDs
2023-2766
Acronym
RECHARJME-RCT
Status last verified
Jan 2026
First submitted
22 Dec 2025
Last updated
8 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ipsos. (n.d.). Life in transition survey IV for the European Bank for Reconstruction and Development: Technical report. The European Bank for Reconstruction and Development. https://www.ebrd.com/content/dam/ebrd_dxp/assets/pdfs/office-of-the-chief-economist/publications/life-in-transition-survey-iv/LITS-IV-Technical-report.pdf

  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.

    PubMed 3397865

  • Sonnentag S, Fritz C. The Recovery Experience Questionnaire: development and validation of a measure for assessing recuperation and unwinding from work. J Occup Health Psychol. 2007 Jul;12(3):204-21. doi: 10.1037/1076-8998.12.3.204.

    PubMed 17638488

  • Carlson LE, Brown KW. Validation of the Mindful Attention Awareness Scale in a cancer population. J Psychosom Res. 2005 Jan;58(1):29-33. doi: 10.1016/j.jpsychores.2004.04.366.

    PubMed 15771867

  • Dagenais-Desmarais, V., & Savoie, A. (2012). What is psychological well-being, really? A grassroots approach from the organizational sciences. Journal of Happiness Studies, 13(4), 659-684.

  • Shirom, A., & Melamed, S. (2006). A comparison of the construct validity of two burnout measures in two groups of professionals. International Journal of Stress Management, 13(2), 176-200

  • Diener, E., Wirtz, D., Tov, W., Kim-Prieto, C., Choi, D. W., Oishi, S., & Biswas-Diener, R. (2010). New well-being measures: Short scales to assess flourishing and positive and negative feelings. Social Indicators Research, 97(2), 143-156.

  • Sassi, N., & Neveu, J. P. (2010). Traduction et validation d'une nouvelle mesure d'épuisement professionnel: Le shirom-melamed burnout measure. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement, 42(3), 177-184.

  • Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601.

    PubMed 21532953

  • Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010 Apr;122(1-2):86-95. doi: 10.1016/j.jad.2009.06.019. Epub 2009 Jul 17.

    PubMed 19616305

  • Kessler RC, Barber C, Beck A, Berglund P, Cleary PD, McKenas D, Pronk N, Simon G, Stang P, Ustun TB, Wang P. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med. 2003 Feb;45(2):156-74. doi: 10.1097/01.jom.0000052967.43131.51.

    PubMed 12625231

  • Lam RW, Michalak EE, Yatham LN. A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder. BMC Psychiatry. 2009 Dec 3;9:78. doi: 10.1186/1471-244X-9-78.

    PubMed 19958540

Questions about this trial

What is this clinical trial studying?

A study testing Recharjme Multi-Modal Rest Cabin in people with Employee Well-being and Work-related Outcomes, run by Laval University at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presenteeism (impaired productivity and troublesome symptoms at work) (time frame: Time 0 (baseline) to time 3 (four months after baseline)). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07322354, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in